A single 25 mg dose of psilocybin, given alongside structured psychological support, produced measurable reductions in depression and anxiety that held for up to two years in a group of cancer patients. Those are the findings of a phase 2 trial now published in Cancer, the peer-reviewed journal of the American Cancer Society, and they […]
One Dose, Two Years: Psilocybin and Depression in Cancer Patients